Invention is an essential feature of business. The best inventions are created when you mix talented people playing to their strengths in an environment of open collaboration, working in partnership with clients and suppliers with a clear focus on commercial goals.
Exciting and varied work that makes a difference. A collaborative culture where you can take on complex technical challenges and deliver commercial impact. That's life at TTP.
Recent industry deals show what automotive lidar companies need to win an OEM order: a credible path to low-cost, compact products. The sensor optics and unconventional optical designs can offer that much-needed edge over competitors, says Alex Coney.
Monoclonal antibodies offer promise in the fight against a wide range of diseases, including COVID-19. The length of the discovery process is a barrier to emergency use, however, and poses a commercial risk for pharmaceutical companies. Multidisciplinary innovation could step up the pace, says Verity Jackson.
Remote user testing allowed us to substantially accelerate the development of the CoVent™ ventilator. Dan Lock reviews the impact of social distancing on user research and finds that many of our necessary adaptations will continue to have value. Yet, each new study challenges us to come up with new approaches to inform medical device development.
To deliver on the promise of greater safety than human drivers, the sensors of autonomous vehicles need to be kept spotlessly clean. Which technology is up to the task, and who will take ownership of what could become a point of competitive advantage in a burgeoning industry, asks Tom Jellicoe.
Sam Hyde shares his views with Red Box for The Times.
TTP consultant, Douglas Bradsahw, was interviewed on Sky News, Ian King Live and discussed CoTest™, TTP's new COVID-19 screening technology to to be used by anyone, anywhere, to screen up to 40 people at once for Covid-19 with results available in 30 minutes.
The Technology Partnership Plc (TTP), a leading independent technology and product development company, is seeking go-to-market partnerships for CoTest, a new pooled screening technology for Covid-19.
